identifying, referring and managing spondyloarthritis … fractures advise people that they may be...

1
© 2017 BMJ Publishing group Ltd. Read the full article online http://bmj.co/spond Disclaimer: This infographic is not a validated clinical decision aid. This information is provided without any representations, conditions or warranties that it is accurate or up to date. BMJ and its licensors assume no responsibility for any aspect of treatment administered with the aid of this information. Any reliance placed on this information is strictly at the user's own risk. For the full disclaimer wording see BMJ's terms and conditions: http://www.bmj.com/company/legal-information/ Managing axial spondyloarthritis Managing flares Managing peripheral spondyloarthritis Pharmacological management Pharmacological management Non-pharma management Non-pharma management There is no “one size fits all” approach to flare management, as patients’ experiences vary and multiple approaches may be appropriate Long term management While there is little evidence to support long term management strategies, there are a number of potential issues to be aware of Supported by UCB through an educational grant. UCB has no editorial control on the contents The production and distribution of this poster was supported by NASS Refer to a rheumatologist for specialist diagnostic assessment Specialist referral Diagnosis in specialist setting No single test can reliably rule out spondyloarthritis. Diagnosis in specialist care will rest on multiple signs, symptoms, and test results Validated SpA criteria may help to guide judgement Imaging, using inflammatory back pain protocol HLA–B27 test results Clinical features Exactly 3 referral criteria 2 or fewer referral critera 4+ referral criteria Physiotherapy Hydrotherapy Also consider referral to: Occupational therapy Therapist Orthotist Etc. Podiatrist Lowest effective dose, with appropriate clinical assessment and monitoring Consider Switching to a different Switch to or add DMARDs Biological After 2–4 weeks, if maximum tolerated dose is ineffective NSAIDs NSAID Refer to a specialist physiotherapist to start a structured exercise programme To manage pain For people having difficulty with daily activities Consider referral to: Occupational therapy Therapist Physiotherapy Orthotist Podiatrist Etc. For people having difficulty with daily activities Peripheral polyarthritis Oligoarthritis Progressive monoarthritis DMARDs Standard For people with psoriatic arthritis, which does not respond to 2 or more standard DMARDs DMARDs Biological Non- progressive monoarthritis Corticosteroid injections + + Short term adjunctive therapy NSAIDs Steroid injections Oral steroids Consider developing a flare management plan, with information on: Seek specialist advice as needed, particularly for: Offer advice on possibility of: Take into account adverse effects associated with: Flare episodes Recurrent or persistent flares People with comorbidities Acute uveitis flares (Ophthalmology input) People taking Extra- articular symptoms Access to care (named individual) Self care: Pain & fatigue management Managing impact on daily life Potential medicine changes DMARDs Biological Exercises Stretching Joint protection NSAIDs DMARDs Standard DMARDs Biological Skin cancer Advise people on risk of skin cancer for those using TNF alpha inhibitors Cardiovascular Discuss risk factors for cardiovascular comorbidities Fractures Advise people that they may be prone to fractures Osteoporosis Consider osteoporosis assessments every two years For people with axial spondyloarthritis: Suspected axial spondyloarthritis Suspected peripheral spondyloarthritis Low back pain HLA-B27 test Advise repeat assessments if new signs, symptoms or risk factors develop. Enthesitis Dactylitis Gout Persistent Multiple sites A concurrent or historic condition Positive + Negative - Back pain without apparent cause Current or past uveitis psoriasis Inflammation of fingers or toes Inflammation of entheses, often in the heel Assess for referral criteria Low back pain that started before the age of 35 years Waking during the second half of the night because of symptoms A first-degree relative with spondyloarthritis Buttock pain Improvement with movement Improvement within 48 hours of taking Current or past arthritis Current or past psoriasis Current or past enthesitis Started before age 45 Lasting longer than 3 months Acute CPP (calcium pyrophosphate) arthritis Usually managed in primary care No apparent mechanical cause or or Gastrointestinal genitourinary infection Inflammatory bowel disease A first-degree relative with spondyloarthritis or psoriasis + Rheumatoid arthritis + No additional features + NSAIDs Suspected new- onset inflammatory arthritis or or Identifying, referring and managing spondyloarthritis Musculoskeletal symptoms Associated conditions Risk factors Spondyloarthritis can have diverse symptoms and be difficult to identify. The presence of these key indicators might prompt you to continue through the more detailed assessments below. Chronic back pain Enthesitis Dactylitis Joint pain in fingers or toes Uveitis Psoriasis Including psoriatic nail symptoms Recent genitourinary infection Family history of spondyloarthritis Family history of psoriasis Visual summary of NICE guidelines Refer acute anterior uveitis urgently to an ophthalmologist* NSAIDs = Non-steroidal anti- inflammatory drugs = Disease-modifying antirheumatic drugs DMARDs Standard DMARDs Biological MRI X-ray Unless skeleton has not fully matured. * Ophthalmologists may refer people directly to a rheumatologist, after following the DUET algorithm (see http://dx.doi.org/10.1136/annrheumdis-2014-205358).

Upload: ngominh

Post on 30-Apr-2018

217 views

Category:

Documents


4 download

TRANSCRIPT

© 2017 BMJ Publishing group Ltd.Read the fullarticle online http://bmj.co/spond Disclaimer: This infographic is not a validated clinical decision aid. This information is provided without any representations,

conditions or warranties that it is accurate or up to date. BMJ and its licensors assume no responsibility for any aspect of treatment administered with the aid of this information. Any reliance placed on this information is strictly at the user's own risk. For the full disclaimer wording see BMJ's terms and conditions: http://www.bmj.com/company/legal-information/

Managing axial spondyloarthritis

Managing �ares

Managing peripheral spondyloarthritis

Pharmacologicalmanagement

Pharmacologicalmanagement

Non-pharmamanagement

Non-pharmamanagement

There is no “one size fits all” approach to flare management, as patients’ experiences vary and multiple approaches may be appropriate

Long term managementWhile there is little evidence to support long term management strategies, there are a number of potential issues to be aware of

Supported by UCB through an educational grant. UCB has no editorial control on the contents

The production and distribution of this poster was supported by NASS

Refer to a rheumatologist for specialist diagnostic assessment

Specialistreferral

Diagnosisin specialist

setting

No single test can reliably rule out spondyloarthritis. Diagnosis in specialist care will rest on multiple signs, symptoms, and test results

Validated SpA criteria may help to guide judgement

Imaging, using inflammatory back pain protocol

HLA–B27 test results

Clinical features

Exactly 3 referral criteria

2 or fewerreferral critera

4+ referralcriteria

Physiotherapy

Hydrotherapy

Also consider referral to:

Occupationaltherapy

Therapist

Orthotist

Etc.Podiatrist

Lowest effective dose, with appropriate clinical

assessment and monitoring

Consider Switching to

a different Switchto or add

DMARDsBiological

After 2–4 weeks, if maximum tolerated dose is ineffective

NSAIDs

NSAID

Refer to a specialist physiotherapist to start a structured

exercise programme

To manage pain

For people having difficulty with daily activities

Consider referral to:

Occupational therapy

Therapist

Physiotherapy

Orthotist

Podiatrist

Etc.

For people having difficulty with daily

activities

Peripheralpolyarthritis

Oligoarthritis

Progressivemonoarthritis

DMARDsStandard

For people with psoriatic

arthritis, which does not respond to 2 or more

standard DMARDs

DMARDsBiological

Non- progressive

monoarthritis

Corticosteroidinjections

+ +Short termadjunctivetherapy

NSAIDsSteroid

injectionsOral

steroids

Consider developing a flare management plan, with information on: Seek specialist advice as needed, particularly for:Offer advice on possibility of:

Take into account adverseeffects associated with:

Flareepisodes

Recurrentor

persistent flares

People with comorbidities

Acute uveitis flares(Ophthalmology input)

People takingExtra-articular

symptoms

Access to care(named individual)

Selfcare:

Pain & fatiguemanagement

Managing impacton daily

lifePotential medicine changes DMARDsBiological

Exercises

Stretching

Joint protection

NSAIDsDMARDsStandard

DMARDsBiological

Skin cancer

Advise people on risk of skin cancer for those

using TNF alpha inhibitors

Cardiovascular

Discuss risk factors for cardiovascular

comorbidities

Fractures

Advise people that they may be prone to fractures

Osteoporosis

Consider osteoporosis assessments every two years

For people with axial spondyloarthritis:

Suspected axial spondyloarthritis Suspected peripheral spondyloarthritis

Low back pain

HLA-B27 testAdvise repeat

assessments if new signs, symptoms or risk

factors develop.

EnthesitisDactylitis

Gout

PersistentMultiple

sitesA concurrent or

historic condition

Positive+Negative-

Back pain without apparent cause Current or past uveitis psoriasis

Inflammation of fingers or toes

Inflammation of entheses, often in the heel

Assess for referral criteria

Low back pain that started before the age of 35 years

Waking during the second half of the night because of symptoms

A first-degree relative with spondyloarthritis Buttock pain

Improvement with movement

Improvement within 48 hours of taking

Current or pastarthritis

Current or pastpsoriasis

Current or pastenthesitis

Started before age 45 Lasting longer than 3 months

Acute CPP (calcium pyrophosphate) arthritis

Usually managed in primary care

No apparent mechanical cause

or or

Gastrointestinal genitourinary infection Inflammatory bowel disease

A first-degree relative with spondyloarthritis or psoriasis

+

Rheumatoid arthritis +No additional features

+

NSAIDs

Suspected new-onset inflammatory

arthritis

or

or

Identifying, referring and managing spondyloarthritis

Musculoskeletalsymptoms

Associated conditions Risk factorsSpondyloarthritis can have diverse symptoms and be difficult to identify. The presence of these key indicators might prompt you to continue through the more detailed assessments below.

Chronic back pain

Enthesitis Dactylitis

Joint pain in fingers or toes

Uveitis Psoriasis

Including psoriatic

nailsymptoms

Recent genitourinaryinfection

Family history ofspondyloarthritis

Family history of psoriasis

Visual summary of NICE guidelines

Refer acute anterior uveitis urgently to an

ophthalmologist*

NSAIDs = Non-steroidal anti- inflammatory drugs

= Disease-modifying antirheumatic drugs DMARDs

StandardDMARDsBiological

MRI X-ray

Unless skeleton has not fully

matured.

* Ophthalmologists may refer people directly to a rheumatologist, after following the DUET algorithm (see http://dx.doi.org/10.1136/annrheumdis-2014-205358).